Skip to main content
Erschienen in: European Radiology 11/2019

26.04.2019 | Chest

Prediction of response after chemoradiation for esophageal cancer using a combination of dosimetry and CT radiomics

verfasst von: Xiance Jin, Xiaomin Zheng, Didi Chen, Juebin Jin, Guojie Zhu, Xia Deng, Ce Han, Changfei Gong, Yongqiang Zhou, Cong Liu, Congying Xie

Erschienen in: European Radiology | Ausgabe 11/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To investigate the treatment response prediction feasibility and accuracy of an integrated model combining computed tomography (CT) radiomic features and dosimetric parameters for patients with esophageal cancer (EC) who underwent concurrent chemoradiation (CRT) using machine learning.

Methods

The radiomic features and dosimetric parameters of 94 EC patients were extracted and modeled using Support Vector Classification (SVM) and Extreme Gradient Boosting algorithm (XGBoost). The 94-sample dataset was randomly divided into a 70-sample training subset and a 24-sample independent test set while keeping the class proportions intact via stratification. A receiver operating characteristic (ROC) curve was used to assess the performance of models using radiomic features alone and using combined radiomic features and dosimetric parameters.

Results

A total of 42 radiomic features and 18 dosimetric parameters plus the patients’ characteristic parameters were extracted for these 94 cases (58 responders and 36 non-responders). XGBoost plus principal component analysis (PCA) achieved an accuracy and area under the curve of 0.708 and 0.541, respectively, for models with radiomic features combined with dosimetric parameters, and 0.689 and 0.479, respectively, for radiomic features alone. Image features of GlobalMean X.333.1, Coarseness, Skewness, and GlobalStd contributed most to the model. The dosimetric parameters of gross tumor volume (GTV) homogeneity index (HI), Cord Dmax, Prescription dose, Heart-Dmean, and Heart-V50 also had a strong contribution to the model.

Conclusions

The model with radiomic features combined with dosimetric parameters is promising and outperforms that with radiomic features alone in predicting the treatment response of patients with EC who underwent CRT.

Key Points

• The model with radiomic features combined with dosimetric parameters is promising in predicting the treatment response of patients with EC who underwent CRT.
• The model with radiomic features combined with dosimetric parameters (prediction accuracy of 0.708 and AUC of 0.689) outperforms that with radiomic features alone (best prediction accuracy of 0.625 and AUC of 0.412).
• The image features of GlobalMean X.333.1, Coarseness, Skewness, and GlobalStd contributed most to the treatment response prediction model. The dosimetric parameters of GTV HI, Cord Dmax, Prescription dose, Heart-Dmean, and Heart-V50 also had a strong contribution to the model.
Literatur
1.
Zurück zum Zitat Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A (2015) Global cancer statistics, 2012. CA Cancer J Clin 65:87–108CrossRef Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A (2015) Global cancer statistics, 2012. CA Cancer J Clin 65:87–108CrossRef
2.
Zurück zum Zitat Wheeler JB, Reed CE (2012) Epidemiology of esophageal cancer. Surg Clin North Am 92:1077–1087CrossRef Wheeler JB, Reed CE (2012) Epidemiology of esophageal cancer. Surg Clin North Am 92:1077–1087CrossRef
3.
Zurück zum Zitat Kumagai K, Rouvelas I, Tsai JA et al (2014) Meta-analysis of postoperative morbidity and perioperative mortality in patients receiving neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal and gastro-oesophageal junctional cancers. Br J Surg 101:321–338CrossRef Kumagai K, Rouvelas I, Tsai JA et al (2014) Meta-analysis of postoperative morbidity and perioperative mortality in patients receiving neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal and gastro-oesophageal junctional cancers. Br J Surg 101:321–338CrossRef
4.
Zurück zum Zitat Li M, Zhang X, Zhao F, Luo Y, Kong L, Yu J (2016) Involved-field radiotherapy for esophageal squamous cell carcinoma: theory and practice. Radiat Oncol 11:18CrossRef Li M, Zhang X, Zhao F, Luo Y, Kong L, Yu J (2016) Involved-field radiotherapy for esophageal squamous cell carcinoma: theory and practice. Radiat Oncol 11:18CrossRef
5.
Zurück zum Zitat Minsky BD, Neuberg D, Kelsen DP et al (1999) Final report of intergroup trial 0122 (ECOG PE-289, RTOG 90-12): phase II trial of neoadjuvant chemotherapy plus concurrent chemotherapy and high-dose radiation for squamous cell carcinoma of the esophagus. Int J Radiat Oncol Biol Phys 43:517–523CrossRef Minsky BD, Neuberg D, Kelsen DP et al (1999) Final report of intergroup trial 0122 (ECOG PE-289, RTOG 90-12): phase II trial of neoadjuvant chemotherapy plus concurrent chemotherapy and high-dose radiation for squamous cell carcinoma of the esophagus. Int J Radiat Oncol Biol Phys 43:517–523CrossRef
6.
Zurück zum Zitat Minsky BD, Pajak TF, Ginsberg RJ et al (2002) INT 0123 (radiation therapy oncology group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. J Clin Oncol 20:1167–1174CrossRef Minsky BD, Pajak TF, Ginsberg RJ et al (2002) INT 0123 (radiation therapy oncology group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. J Clin Oncol 20:1167–1174CrossRef
7.
Zurück zum Zitat Ajani JA (2008) Gastroesophageal cancers: progress and problems. J Natl Compr Canc Netw 6:813–814CrossRef Ajani JA (2008) Gastroesophageal cancers: progress and problems. J Natl Compr Canc Netw 6:813–814CrossRef
8.
Zurück zum Zitat Luo Y, Mao Q, Wang X, Yu J, Li M (2017) Radiotherapy for esophageal carcinoma: dose, response and survival. Cancer Manag Res 10:13–21CrossRef Luo Y, Mao Q, Wang X, Yu J, Li M (2017) Radiotherapy for esophageal carcinoma: dose, response and survival. Cancer Manag Res 10:13–21CrossRef
9.
Zurück zum Zitat Li JC, Liu D, Chen MQ et al (2012) Different radiation treatment in esophageal carcinoma: a clinical comparative study. J BUON 17:512–516PubMed Li JC, Liu D, Chen MQ et al (2012) Different radiation treatment in esophageal carcinoma: a clinical comparative study. J BUON 17:512–516PubMed
10.
Zurück zum Zitat Chen YJ, Liu A, Han C et al (2007) Helical tomotherapy for radiotherapy in esophageal cancer: a preferred plan with better conformal target coverage and more homogeneous dose distribution. Med Dosim 32:166–171CrossRef Chen YJ, Liu A, Han C et al (2007) Helical tomotherapy for radiotherapy in esophageal cancer: a preferred plan with better conformal target coverage and more homogeneous dose distribution. Med Dosim 32:166–171CrossRef
11.
Zurück zum Zitat Tong DK, Law S, Kwong DL, Chan KW, Lam AK, Wong KH (2010) Histological regression of squamous esophageal carcinoma assessed by percentage of residual viable cells after neoadjuvant chemoradiation is an important prognostic factor. Ann Surg Oncol 17:2184–2192CrossRef Tong DK, Law S, Kwong DL, Chan KW, Lam AK, Wong KH (2010) Histological regression of squamous esophageal carcinoma assessed by percentage of residual viable cells after neoadjuvant chemoradiation is an important prognostic factor. Ann Surg Oncol 17:2184–2192CrossRef
12.
Zurück zum Zitat Chao YK, Chan SC, Liu YH et al (2009) Pretreatment T3–4 stage is an adverse prognostic factor in patients with esophageal squamous cell carcinoma who achieve pathological complete response following preoperative chemoradiotherapy. Ann Surg 249:392–396CrossRef Chao YK, Chan SC, Liu YH et al (2009) Pretreatment T3–4 stage is an adverse prognostic factor in patients with esophageal squamous cell carcinoma who achieve pathological complete response following preoperative chemoradiotherapy. Ann Surg 249:392–396CrossRef
13.
Zurück zum Zitat Hammoud ZT, Kesler KA, Ferguson MK et al (2006) Survival outcomes of resected patients who demonstrate a pathologic complete response after neoadjuvant chemoradiation therapy for locally advanced esophageal cancer. Dis Esophagus 19:69–72CrossRef Hammoud ZT, Kesler KA, Ferguson MK et al (2006) Survival outcomes of resected patients who demonstrate a pathologic complete response after neoadjuvant chemoradiation therapy for locally advanced esophageal cancer. Dis Esophagus 19:69–72CrossRef
14.
Zurück zum Zitat Muijs CT, Beukema JC, Pruim J et al (2010) A systematic review on the role of FDG-PET/CT in tumour delineation and radiotherapy planning in patients with esophageal cancer. Radiother Oncol 97:165–171CrossRef Muijs CT, Beukema JC, Pruim J et al (2010) A systematic review on the role of FDG-PET/CT in tumour delineation and radiotherapy planning in patients with esophageal cancer. Radiother Oncol 97:165–171CrossRef
15.
Zurück zum Zitat Foley KG, Hills RK, Berthon B et al (2018) Development and validation of a prognostic model incorporating texture analysis derived from standardised segmentation of PET in patients with oesophageal cancer. Eur Radiol 28(1):428–436CrossRef Foley KG, Hills RK, Berthon B et al (2018) Development and validation of a prognostic model incorporating texture analysis derived from standardised segmentation of PET in patients with oesophageal cancer. Eur Radiol 28(1):428–436CrossRef
16.
Zurück zum Zitat Miles KA, Lee TY, Goh V et al (2012) Experimental Cancer Medicine Centre Imaging Network Group. Current status and guidelines for the assessment of tumour vascular support with dynamic contrast-enhanced computed tomography. Eur Radiol 22:1430–1441CrossRef Miles KA, Lee TY, Goh V et al (2012) Experimental Cancer Medicine Centre Imaging Network Group. Current status and guidelines for the assessment of tumour vascular support with dynamic contrast-enhanced computed tomography. Eur Radiol 22:1430–1441CrossRef
17.
Zurück zum Zitat Djuric-Stefanovic A, Micev M, Stojanovic-Rundic S, Pesko P, Dj S (2015) Absolute CT perfusion parameter values after the neoadjuvant chemoradiotherapy of the squamous cell esophageal carcinoma correlate with the histopathologic tumor regression grade. Eur J Radiol 84:2477–2484CrossRef Djuric-Stefanovic A, Micev M, Stojanovic-Rundic S, Pesko P, Dj S (2015) Absolute CT perfusion parameter values after the neoadjuvant chemoradiotherapy of the squamous cell esophageal carcinoma correlate with the histopathologic tumor regression grade. Eur J Radiol 84:2477–2484CrossRef
18.
Zurück zum Zitat Desborders P, Ruan S, Modzelewski R et al (2017) Predictive value of initial FDG-PET features for treatment response and survival in esophageal cancer patients treated with chemo-radiation therapy using a random forest classifier. PLoS One 12:e0173208CrossRef Desborders P, Ruan S, Modzelewski R et al (2017) Predictive value of initial FDG-PET features for treatment response and survival in esophageal cancer patients treated with chemo-radiation therapy using a random forest classifier. PLoS One 12:e0173208CrossRef
19.
Zurück zum Zitat Tixier F, Rest CC, Hatt M et al (2011) Intratumor heterogeneity characterized by textural features on baseline 18F-FDG PET images predicts response to concomitant radiochemotherapy in esophageal cancer. J Nucl Med 52:369–378CrossRef Tixier F, Rest CC, Hatt M et al (2011) Intratumor heterogeneity characterized by textural features on baseline 18F-FDG PET images predicts response to concomitant radiochemotherapy in esophageal cancer. J Nucl Med 52:369–378CrossRef
20.
Zurück zum Zitat Ganeshan B, Skogen K, Pressney I, Coutroubis D, Miles K (2012) Tumour heterogeneity in esophageal cancer assessed by CT texture analysis: preliminary evidence of an association with tumour metabolism, stage, and survival. Clin Radiol 67:157–164CrossRef Ganeshan B, Skogen K, Pressney I, Coutroubis D, Miles K (2012) Tumour heterogeneity in esophageal cancer assessed by CT texture analysis: preliminary evidence of an association with tumour metabolism, stage, and survival. Clin Radiol 67:157–164CrossRef
21.
Zurück zum Zitat Hou Z, Ren W, Li S et al (2017) Radiomic analysis in contrast-enhanced CT: predict treatment response to chemoradiotherapy in esophageal carcinoma. Oncotarget 8:104444–104454PubMedPubMedCentral Hou Z, Ren W, Li S et al (2017) Radiomic analysis in contrast-enhanced CT: predict treatment response to chemoradiotherapy in esophageal carcinoma. Oncotarget 8:104444–104454PubMedPubMedCentral
22.
Zurück zum Zitat Jin X, Yi J, Zhou Y, Yan H, Han C, Xie C (2013) CRT combined with a sequential VMAT boost in the treatment of upper thoracic esophageal cancer. J Appl Clin Med Phys 14:153–161CrossRef Jin X, Yi J, Zhou Y, Yan H, Han C, Xie C (2013) CRT combined with a sequential VMAT boost in the treatment of upper thoracic esophageal cancer. J Appl Clin Med Phys 14:153–161CrossRef
23.
Zurück zum Zitat Wu Z, Xie C, Hu M et al (2014) Dosimetric benefits of IMRT and VMAT in the treatment of middle thoracic esophageal cancer: is the conformal radiotherapy still an alternative option? J Appl Clin Med Phys 15:93–101CrossRef Wu Z, Xie C, Hu M et al (2014) Dosimetric benefits of IMRT and VMAT in the treatment of middle thoracic esophageal cancer: is the conformal radiotherapy still an alternative option? J Appl Clin Med Phys 15:93–101CrossRef
24.
Zurück zum Zitat Zhang L, Fried DV, Fave XJ, Hunter LA, Yang J, Court LE (2015) IBEX: an open infrastructure software platform to facilitate collaborative work in radiomics. Med Phys 42:1341–1353CrossRef Zhang L, Fried DV, Fave XJ, Hunter LA, Yang J, Court LE (2015) IBEX: an open infrastructure software platform to facilitate collaborative work in radiomics. Med Phys 42:1341–1353CrossRef
25.
Zurück zum Zitat Blaas J, Botha CP, Post FH (2008) Extensions of parallel coordinates for interactive exploration of large multi-timepoint data sets. IEEE Trans Vis Comput Graph 14:1436–1443CrossRef Blaas J, Botha CP, Post FH (2008) Extensions of parallel coordinates for interactive exploration of large multi-timepoint data sets. IEEE Trans Vis Comput Graph 14:1436–1443CrossRef
26.
Zurück zum Zitat Burges CJC (1998) A tutorial on support vector machines for pattern recognition. Data Min Knowl Discov 2:121–167CrossRef Burges CJC (1998) A tutorial on support vector machines for pattern recognition. Data Min Knowl Discov 2:121–167CrossRef
27.
Zurück zum Zitat Chen T, Guestrin C (2016) XGBoost: a scalable tree boosting system. AcmSigkdd international conference on Knowledge Discovery & Data Mining, pp 785–94 Chen T, Guestrin C (2016) XGBoost: a scalable tree boosting system. AcmSigkdd international conference on Knowledge Discovery & Data Mining, pp 785–94
28.
Zurück zum Zitat Minka TP (2001) Automatic choice of dimensionality for PCA. In: Advances in neural information processing systems, pp 598–604 Minka TP (2001) Automatic choice of dimensionality for PCA. In: Advances in neural information processing systems, pp 598–604
29.
Zurück zum Zitat Ganeshan B, Skogen K, Pressney I, Coutroubis D, Miles K (2012) Tumour heterogeneity in oesophageal cancer assessed by CT texture analysis: preliminary evidence of an association with tumour metabolism, stage, and survival. Clin Radiol 67:157–164CrossRef Ganeshan B, Skogen K, Pressney I, Coutroubis D, Miles K (2012) Tumour heterogeneity in oesophageal cancer assessed by CT texture analysis: preliminary evidence of an association with tumour metabolism, stage, and survival. Clin Radiol 67:157–164CrossRef
30.
Zurück zum Zitat Yip C, Davnall F, Kozarski R, Landau DB et al (2015) Assessment of changes in tumor heterogeneity following neoadjuvant chemotherapy in primary esophageal cancer. Dis Esophagus 28:172–179CrossRef Yip C, Davnall F, Kozarski R, Landau DB et al (2015) Assessment of changes in tumor heterogeneity following neoadjuvant chemotherapy in primary esophageal cancer. Dis Esophagus 28:172–179CrossRef
31.
Zurück zum Zitat Lloyd S, Chang BW (2014) Current strategies in chemoradiation for esophageal cancer. J Gastrointest Oncol 5:156–165PubMedPubMedCentral Lloyd S, Chang BW (2014) Current strategies in chemoradiation for esophageal cancer. J Gastrointest Oncol 5:156–165PubMedPubMedCentral
32.
Zurück zum Zitat O'Sullivan KE, Hurley ET, Hurley JP (2015) Understanding complete pathologic response in oesophageal cancer: implications for management and survival. Gastroenterol Res Pract 2015(2015):518281PubMedPubMedCentral O'Sullivan KE, Hurley ET, Hurley JP (2015) Understanding complete pathologic response in oesophageal cancer: implications for management and survival. Gastroenterol Res Pract 2015(2015):518281PubMedPubMedCentral
Metadaten
Titel
Prediction of response after chemoradiation for esophageal cancer using a combination of dosimetry and CT radiomics
verfasst von
Xiance Jin
Xiaomin Zheng
Didi Chen
Juebin Jin
Guojie Zhu
Xia Deng
Ce Han
Changfei Gong
Yongqiang Zhou
Cong Liu
Congying Xie
Publikationsdatum
26.04.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
European Radiology / Ausgabe 11/2019
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-019-06193-w

Weitere Artikel der Ausgabe 11/2019

European Radiology 11/2019 Zur Ausgabe

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

S3-Leitlinie zu Pankreaskrebs aktualisiert

23.04.2024 Pankreaskarzinom Nachrichten

Die Empfehlungen zur Therapie des Pankreaskarzinoms wurden um zwei Off-Label-Anwendungen erweitert. Und auch im Bereich der Früherkennung gibt es Aktualisierungen.

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

18.04.2024 Pädiatrische Notfallmedizin Nachrichten

Im Choosing-Wisely-Programm, das für die deutsche Initiative „Klug entscheiden“ Pate gestanden hat, sind erstmals Empfehlungen zum Umgang mit Notfällen von Kindern erschienen. Fünf Dinge gilt es demnach zu vermeiden.

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

13.04.2024 Klinik aktuell Kongressbericht

Die Teilnehmer eines Forums beim DGIM-Kongress waren sich einig: Fehler in der Medizin sind häufig in ungeeigneten Prozessen und mangelnder Kommunikation begründet. Gespräche mit Patienten und im Team können helfen.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.